Pad Chivukula insider trades: Arcturus Therapeutics Holdings (ARCT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Pad reports to the SEC
Open-market buys and sales
31 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | ARCT | ↓ Sell | 12,000 | $20.76 | $249K | Direct | Oct 16, 2024 (1d) |
| Jun 5, 2024 | ARCT | ↓ Sell | 114 | $45.00 | $5K | Direct | Jun 7, 2024 (2d) |
| Jun 3, 2024 | ARCT | ↓ Sell | 26,000 | $40.01 | $1.0M | Direct | Jun 4, 2024 (1d) |
| Mar 25, 2024 | ARCT | ↓ Sell | 17,435 | $35.02 | $611K | Direct | Mar 27, 2024 (2d) |
| Mar 19, 2024 | ARCT | ↓ Sell | 8,565 | $35.01 | $300K | Direct | Mar 21, 2024 (2d) |
| Nov 1, 2023 | ARCT | ↓ Sell | 5,000 | $18.72 | $94K | Direct | Nov 3, 2023 (2d) |
| Oct 2, 2023 | ARCT | ↓ Sell | 5,000 | $25.61 | $128K | Direct | Oct 4, 2023 (2d) |
| Sep 1, 2023 | ARCT | ↓ Sell | 5,000 | $31.45 | $157K | Direct | Sep 5, 2023 (4d) |
| Aug 1, 2023 | ARCT | ↓ Sell | 5,000 | $34.91 | $175K | Direct | Aug 3, 2023 (2d) |
| Jul 14, 2023 | ARCT | ↓ Sell | 25,000 | $35.01 | $875K | Direct | Jul 18, 2023 (4d) |
| Jul 3, 2023 | ARCT | ↓ Sell | 5,000 | $28.75 | $144K | Direct | Jul 7, 2023 (4d) |
| Jun 1, 2023 | ARCT | ↓ Sell | 5,000 | $27.16 | $136K | Direct | Jun 5, 2023 (4d) |
| May 11, 2023 | ARCT | ↓ Sell | 25,000 | $30.08 | $752K | Direct | May 12, 2023 (1d) |
| May 1, 2023 | ARCT | ↓ Sell | 5,000 | $25.93 | $130K | Direct | May 3, 2023 (2d) |
| Apr 3, 2023 | ARCT | ↓ Sell | 5,000 | $25.38 | $127K | Direct | Apr 5, 2023 (2d) |
| Mar 6, 2023 | ARCT | ↓ Sell | 5,000 | $16.07 | $80K | Direct | Mar 8, 2023 (2d) |
| Jan 4, 2022 | ARCT | ↓ Sell | 8,100 | $40.00 | $324K | Direct | Jan 6, 2022 (2d) |
| Dec 16, 2021 | ARCT | ↓ Sell | 3,633 | $40.00 | $145K | Direct | Dec 20, 2021 (4d) |
| Dec 8, 2021 | ARCT | ↓ Sell | 6,367 | $40.00 | $255K | Direct | Dec 10, 2021 (2d) |
| Nov 1, 2021 | ARCT | ↓ Sell | 10,000 | $44.41 | $444K | Direct | Nov 3, 2021 (2d) |
| Oct 1, 2021 | ARCT | ↓ Sell | 10,000 | $44.36 | $444K | Direct | Oct 4, 2021 (3d) |
| Sep 1, 2021 | ARCT | ↓ Sell | 10,000 | $55.86 | $559K | Direct | Sep 2, 2021 (1d) |
| Aug 3, 2021 | ARCT | ↓ Sell | 10,000 | $40.07 | $401K | Direct | Aug 5, 2021 (2d) |
| Apr 1, 2021 | ARCT | ↓ Sell | 10,000 | $42.95 | $430K | Direct | Apr 5, 2021 (4d) |
| Mar 1, 2021 | ARCT | ↓ Sell | 10,000 | $54.23 | $542K | Direct | Mar 3, 2021 (2d) |
| Feb 1, 2021 | ARCT | ↓ Sell | 10,000 | $75.31 | $753K | Direct | Feb 3, 2021 (2d) |
| Jan 4, 2021 | ARCT | ↓ Sell | 10,000 | $46.40 | $464K | Direct | Jan 5, 2021 (1d) |
| Dec 1, 2020 | ARCT | ↓ Sell | 10,000 | $96.19 | $962K | Direct | Dec 3, 2020 (2d) |
| Nov 2, 2020 | ARCT | ↓ Sell | 10,000 | $55.28 | $553K | Direct | Nov 3, 2020 (1d) |
| Oct 1, 2020 | ARCT | ↓ Sell | 10,000 | $42.83 | $428K | Direct | Oct 2, 2020 (1d) |
| Sep 3, 2020 | ARCT | ↓ Sell | 10,000 | $45.16 | $452K | Direct | Sep 4, 2020 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Pad Chivukula's insider trades
Pad Chivukula is Chief Scientific Officer & COO at Arcturus Therapeutics Holdings (ARCT). Since Sep 3, 2020, Pad has reported no open-market purchases and 31 sales worth $12.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARCT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.